SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000818686-11-000051
Filing Date
2011-05-17
Accepted
2011-05-17 11:05:39
Documents
3
Period of Report
2009-04-01

Document Format Files

Seq Description Document Type Size
1 TEVA AND CURETECH ANNOUNCE POSITIVE PHASE II DATA FROM CT-011, AN INVESTIGATIONA curetech170511.htm 6-K 60533
2 GRAPHIC image001.jpg GRAPHIC 3735
4 TEVA AND CURETECH ANNOUNCE POSITIVE PHASE II DATA FROM CT-011, AN INVESTIGATIONA curetech170511.pdf 6-K 32787
  Complete submission text file 0000818686-11-000051.txt   112289
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-16174 | Film No.: 11850298
SIC: 2834 Pharmaceutical Preparations